0001493152-21-025508.txt : 20211015
0001493152-21-025508.hdr.sgml : 20211015
20211015104842
ACCESSION NUMBER: 0001493152-21-025508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211014
FILED AS OF DATE: 20211015
DATE AS OF CHANGE: 20211015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reich Samuel J
CENTRAL INDEX KEY: 0001394645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 211325172
MAIL ADDRESS:
STREET 1: ACUITY PHARMACEUTICALS INC
STREET 2: 3701 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Big Cypress Acquisition Corp.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 W. 41ST STREET
STREET 2: SUITE 202
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
BUSINESS PHONE: (305) 204-3338
MAIL ADDRESS:
STREET 1: 300 W. 41ST STREET
STREET 2: SUITE 202
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
4
1
ownership.xml
X0306
4
2021-10-14
0
0001833214
Big Cypress Acquisition Corp.
BCYP
0001394645
Reich Samuel J
C/O BIG CYPRESS ACQUISITION CORP.
300 W. 41ST STREET, SUITE 202
MIAMI BEACH
FL
33140
1
1
1
0
CEO and CFO
Common Stock
2021-10-14
4
P
0
1000
10.11
A
1000
D
Common Stock
3047825
I
See footnote
Represents 1,000 shares of the issuer's common stock acquired jointly by the reporting person and the reporting person's spouse in open market transactions.
Includes 3,047,825 shares of the issuer's common stock held directly by Big Cypress Holdings LLC (the "Sponsor") and indirectly by Samuel J. Reich and Ilan Katz as managers of the Sponsor, which includes 417,200 private placement units of the issuer. The private placement units were purchased in a private placement that closed simultaneously with the closing of the issuer's initial public offering, and each such unit consists of one share of common stock of the issuer and one-half of one warrant of the issuer. The warrants included in the units will become exercisable, if at all, on the later of 30 days after the completion of the issuer's initial business combination and 12 months from the closing of the issuer' initial public offering.
/s/ Samuel J. Reich
2021-10-15